cr-001
·Code: SKB118
cr-001: 1 clinical trial tracked.
cr-001 evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about cr-001, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trials (1)
A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Primary endpoint: Dose Escalation - Incidence and nature of dose-limiting toxicities
Interventionalopen290 targetStarted 2026-02Completion 2029-0228 sites · Australia, Ireland, Italy, Romania…Crescent Biopharma, Inc.